• linkedin
  • Increase Font
  • Sharebar

    The 5 Latest FDA Drug Approvals

    The FDA has already approved 24 new drugs in 2017.



    KEVZARA (sarilumab), Regeneron

    Indications: The treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).

    Dosage: May be used as monotherapy or in combination with methotrexate or other conventional DMARDs. 200 mg once every 2 weeks, administered as a subcutaneous injection.

    Contraindications: Patients with known hypersensitivity to sarilumab or any of the inactive ingredients.

    Check out the Drug Topics New Drug Review here

    Read the full label here

    Previous ButtonNext Button



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available